Indrayani Biotech Limited (BOM:526445)

Indrayani Biotech Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-15.57	63.65	87.37	43.93	-112.14
Depreciation & Amortization	33.68	38.05	33.47	6.59	4.58
Asset Writedown & Restructuring Costs	-	-	5	-	20.97
Loss (Gain) on Equity Investments	-	-	-	-	0.03
Other Operating Activities	92.88	138.9	87.18	19.11	19.65
Change in Accounts Receivable	-191.61	-95.57	-158.73	-93.33	22.77
Change in Inventory	10.09	-301.37	-106.82	-4.43	39.82
Change in Accounts Payable	-138.08	146.52	169.18	24.77	-29.21
Change in Other Net Operating Assets	141.18	-293.72	45.22	44.46	36.09
Operating Cash Flow	-67.42	-303.54	161.88	41.11	2.56
Operating Cash Flow Growth	-	-	293.76%	1506.49%	-
Capital Expenditures	-13.76	-163.02	-215.28	-11.89	-6.96
Sale of Property, Plant & Equipment	74.67	0.66	-	-	0.12
Cash Acquisitions	-	-	-195.21	-0.18	0.01
Investment in Securities	-0.25	-	-2.23	-	-
Other Investing Activities	180.04	-1.86	-	-	-
Investing Cash Flow	247.43	-163.39	-473.94	-5.58	-7.02
Long-Term Debt Issued	-	372.26	225.85	5.5	12.1
Long-Term Debt Repaid	-64.3	-8.48	-4.63	-13.69	-
Net Debt Issued (Repaid)	-64.3	363.78	221.22	-8.19	12.1
Issuance of Common Stock	-	46.33	232.82	-	-
Other Financing Activities	-118.66	32.28	-126.64	-19.11	-14.87
Financing Cash Flow	-182.95	442.39	327.39	-27.3	-2.77
Miscellaneous Cash Flow Adjustments	-	-	-	-1.43	0
Net Cash Flow	-2.94	-24.55	15.33	6.8	-7.23
Free Cash Flow	-81.17	-466.56	-53.4	29.22	-4.4
Free Cash Flow Margin	-6.23%	-28.07%	-3.28%	4.75%	-2.08%
Free Cash Flow Per Share	-1.78	-10.25	-1.23	0.85	-0.12
Cash Interest Paid	-	-	55.57	18.8	19.61
Levered Free Cash Flow	-524.5	-478.55	-301.61	-31.24	21.16
Unlevered Free Cash Flow	-457.52	-416.79	-270.36	-19.82	33.09
Change in Working Capital	-178.42	-544.14	-51.14	-28.53	69.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.